Buscar
Mostrando ítems 21-30 de 970
SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes
(2022)
Using levels of neutralizing antibodies (nAbs), we evaluate the successful Chilean SARS-CoV-2 vaccine campaign, which combines different vaccine technologies and heterologous boosters.
From a population-based study performed ...
Immunopathology, host-virus genome interactions, and effective vaccine de‐ velopment in SARS-CoV-2
Coronaviruses are a group of enveloped RNA viruses that are diversely found in humans and
now declared a global pandemic by the World Health Organization in March 2020. The
population's susceptibility to these highly ...
Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2
On-going pandemic pneumonia outbreak COVID-19 has raised an urgent public health issue
worldwide impacting millions of people with a continuous increase in both morbidity and
mortality. The causative agent of this disease ...
SARS-CoV-2’s Variants of Concern: A Brief Characterization
(Frontiers Media, 2023)
Current development of COVID-19 diagnostics, vaccines and therapeutics
A novel coronavirus, designated as SARS-CoV-2, first emerged in Wuhan City, Hubei Province, China, in
late December 2019. The rapidly increasing number of cases has caused worldwide panic. In this review,
we describe ...
The story behind Chile’s rapid rollout of COVID-19 vaccination
(2021)
Surprisingly, Chile was among the most successful nations worldwide in terms of both, vaccine availability and implementation and rollout of the vaccine program. Since vaccines currently are the most promising tool to ...
Is Gamma (P.1) Variant Associated with a Higher Severity in ICU Patients with SARS-CoV-2 Infection
(2022)
The Omicron variant of SARS-CoV-2 has been shown to evade neutralizing antibodies elicited by vaccination or infection. Despite the global spread of the Omicron variant, even among highly vaccinated populations, death rates ...
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
(2022)
Background: Knowing whether COVID-19 vaccine effectiveness wanes is crucial for informing vaccine policy, such as the need for and timing of booster doses. We aimed to systematically review the evidence for the duration ...